SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-005637
Filing Date
2022-04-13
Accepted
2022-04-13 09:00:55
Documents
12
Period of Report
2022-04-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K onct-20220413.htm   iXBRL 8-K 57301
  Complete submission text file 0000950170-22-005637.txt   177085

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT onct-20220413.xsd EX-101.SCH 2493
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT onct-20220413_lab.xml EX-101.LAB 13848
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT onct-20220413_pre.xml EX-101.PRE 11040
6 EXTRACTED XBRL INSTANCE DOCUMENT onct-20220413_htm.xml XML 4717
Mailing Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Filer) CIK: 0001260990 (see all company filings)

IRS No.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50549 | Film No.: 22823771
SIC: 2834 Pharmaceutical Preparations